Evidence map›Paper›PMID 24043482›Full record

Trial reportClinical oral investigations2014

A randomized clinical trial on the use of medical Portland cement, MTA and calcium hydroxide in indirect pulp treatment.

Marina Agathi Petrou, Fadi Alhaddad Alhamoui, Alexander Welk, Mohammed Basel Altarabulsi, Mohammed Alkilzy, Christian H Splieth

2 registry-linked trialsAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Clinical oral investigations, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02799927 phase2 / phase3unknown statusnot on this map

A Split-mouth Trial Comparing Biodentine and Calcium Hydroxide in the Indirect Pulp Treatment on Primary Teeth

TypeinterventionalSponsorJosé Arturo Garrocho RangelRan2014 to 2016Enrolled80ConditionsDental CariesArmsIndirect Pulp Treatment with Bioactive Dentin Substitute, Indirect Pulp treatment with Calcium hydroxide
NCT03214770 phase1unknown statusnot on this mapstarted 2018, after this paper: background citation

Antibacterial Effect of Light-activated Calcium Silicate Versus Calcium Hydroxide on Permanent Carious Molars Treated With Step-wise Excavation (A Randomized Clinical Trial)

TypeinterventionalSponsorCairo UniversityRan2018 to 2019Enrolled48ConditionsDental Caries Extending Into DentinArmsTheraCal, light-cured calcium hydroxide
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Direct pulp capping in asymptomatic carious primary molars using three different pulp capping materials: a prospective clinical trial.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2022
    Trial
  5. Trial
  6. Trial
  7. Clinical and radiographic evaluation of Portland cement added to radiopacifying agents in primary molar pulpotomies.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2015
    Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marina Agathi PetrouDepartment of Preventive and Paediatric Dentistry, University of Greifswald, Greifswald, Germany, petrou.marina@yahoo.com.
Fadi Alhaddad Alhamoui
Alexander Welk
Mohammed Basel Altarabulsi
Mohammed Alkilzy
Christian H Splieth
Universität Greifswald · DEUniversitätsmedizin Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesStudies on indirect pulp treatment (IPT) show varying success rates of 73 to 97 %. The necessity of re-opening the cavity and the question of the optimal capping material is still under debate. The aim of this prospective in vivo study was to compare the clinical and microbiological outcomes of mineral trioxide aggregate (MTA), medical Portland cement, and calcium hydroxide on the dentin-pulp complex of permanent and primary teeth treated with two-step IPT. MATERIALS AND

methodsIn 86 regular patients (51 % men; 49 % women; age 17.2 years ±13.8), one deep carious lesion each was treated with incomplete caries removal, randomly selected capping with either calcium hydroxide (n = 31), medical Portland cement (29) or white MTA (26), and re-entry (6.3 months ±1.0). Clinical (color, humidity, and consistency of dentin) and microbiological (Lactobacilli/Mutans Strep. counts) parameters were recorded at the first and second treatment.

resultsThe IPT had a high success rate of 90.3 % regardless of the material used (p = 0.72). The arrested lesions showed consistently darker, dry, and therefore, sclerotic dentine (p < 0.05) as well as a decrease in bacterial counts at re-entry (Lactobacilli p = 0.01/Mutans Strep. p = 0.07).

conclusionsThe findings of this study support the use of the IPT as a treatment for deep carious lesions preferably with non-resorbing materials such as MTA or medical Portland cement. CLINICAL RELEVANCE: The findings of this study could promote the improvement of the IPT as a one-step treatment of deep carious lesions when the remaining demineralized dentin would be sealed with durable restorations.

Indexed as

Aluminum CompoundsCalcium CompoundsCalcium HydroxideDental CementsOxidesSilicatesAdolescentAdultChildChild, PreschoolDental PulpDrug CombinationsFemaleHumansMaleYoung AdultAluminum CompoundsCalcium CompoundsCalcium HydroxideDental CementsDrug Combinationsmineral trioxide aggregateOxidesSilicates

Identifiers

PMID24043482
OpenAlexW2015591598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.